CSIMarket
 


Renovorx Inc   (RNXT)
Other Ticker:  
 

Cumulative Renovorx Inc 's Quick Ratio for Trailing Twelve Months Period

RNXT's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

RNXT Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 76.32 % - - - -
Y / Y Cash & cash equivalent Growth -54.22 % - - - -
Quick Ratio for Trailing Twelve Months Period 10.33 13.88 15.51 21.06 28.36
Total Ranking # # 292 # 259 # #
Seq. Current Liabilities Growth -1.87 % -20.13 % 49.89 % 50.08 % -
Seq. Cash & cash equivalent Growth -24.63 % -17.96 % -13.63 % -14.29 % -


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $1 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 10.33 below Renovorx Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry Renovorx Inc achieved highest Quick Ratio for Trailing Twelve Months Period. While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to , from total ranking in previous quarter at 292.

What is Quick Ratio?
Learn more about RNXT
Quick Ratio RNXT in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
15.67 14.78 13.88
(Mar 31 2022)   (Jun 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Nuvalent Inc   28.15 
Synaptogenix Inc   27.97 
Diamedica Therapeutics Inc   27.74 
Kezar Life Sciences Inc   27.63 
Xortx Therapeutics Inc   26.89 
Edgewise Therapeutics inc.  26.69 
Janux Therapeutics Inc   26.66 
Spruce Biosciences Inc   26.18 
Pmv Pharmaceuticals Inc   26.04 
Immuneering Corp  25.90 
Merrimack Pharmaceuticals Inc  25.87 
Karuna Therapeutics Inc   25.77 
Dice Therapeutics Inc   25.43 
Gemini Therapeutics Inc   25.42 
Olema Pharmaceuticals inc   24.70 
Anaptysbio inc  24.68 
Cyteir Therapeutics Inc   24.17 
Silverback Therapeutics Inc   23.90 
Cassava Sciences Inc   23.60 
Kura Oncology Inc   23.54 
Imago Biosciences Inc   23.46 
Sensei Biotherapeutics Inc   23.27 
Astria Therapeutics inc   23.05 
Anixa Biosciences Inc   22.52 
Oramed Pharmaceuticals Inc   22.19 
Rani Therapeutics Holdings Inc   21.67 
Eliem Therapeutics Inc   21.40 
Arena Pharmaceuticals Inc   21.27 
Kinnate Biopharma Inc   20.82 
Generation Bio Co   20.76 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KIND's Profile

Stock Price

KIND's Financials

Business Description

Fundamentals

Charts & Quotes

KIND's News

Suppliers

KIND's Competitors

Customers & Markets

Economic Indicators

KIND's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071